V. Mariano

Optimized glycaemic control achieved with add‐on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine

Gian Paolo Fadini, Saula Vigili de Kreutzenberg, V. Mariano et al. · Diabetes Obesity and Metabolism · 2011 · 54 citations

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 34 citations · Full text

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 31 citations · Full text

Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study

Silvia Galasso, Andrea Facchinetti, Benedetta Maria Bonora et al. · Nutrition Metabolism and Cardiovascular Diseases · 2016 · 26 citations

Metabolic Syndrome, Type 1, Diabetes Management +8

Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy

Liliana Indelicato, V. Mariano, Silvia Galasso et al. · Diabetic Medicine · 2017 · 23 citations